Aristotle Atlantic Partners LLC Sells 5,738 Shares of Synopsys, Inc. (NASDAQ:SNPS)

Aristotle Atlantic Partners LLC lowered its holdings in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 5.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 100,633 shares of the semiconductor company's stock after selling 5,738 shares during the quarter. Synopsys accounts for about 1.5% of Aristotle Atlantic Partners LLC's investment portfolio, making the stock its 18th biggest position. Aristotle Atlantic Partners LLC owned about 0.07% of Synopsys worth $48,843,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Nordea Investment Management AB grew its stake in shares of Synopsys by 15.9% in the 4th quarter. Nordea Investment Management AB now owns 1,043,995 shares of the semiconductor company's stock valued at $509,261,000 after purchasing an additional 143,284 shares during the period. James Hambro & Partners LLP boosted its stake in Synopsys by 30.9% in the 4th quarter. James Hambro & Partners LLP now owns 201,460 shares of the semiconductor company's stock valued at $97,725,000 after buying an additional 47,527 shares in the last quarter. Janney Capital Management LLC bought a new stake in Synopsys in the fourth quarter valued at $6,082,000. Artemis Investment Management LLP raised its stake in Synopsys by 4.5% during the fourth quarter. Artemis Investment Management LLP now owns 24,878 shares of the semiconductor company's stock worth $12,075,000 after acquiring an additional 1,081 shares in the last quarter. Finally, Fiera Capital Corp lifted its holdings in shares of Synopsys by 33.8% during the fourth quarter. Fiera Capital Corp now owns 196,391 shares of the semiconductor company's stock valued at $95,320,000 after acquiring an additional 49,653 shares during the period. Institutional investors and hedge funds own 85.47% of the company's stock.

Insider Transactions at Synopsys

In related news, insider Geus Aart De sold 15,705 shares of Synopsys stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the transaction, the insider now owns 116,671 shares of the company's stock, valued at $51,850,925.82. This trade represents a 11.86 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Sassine Ghazi sold 11,366 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the completion of the sale, the chief executive officer now directly owns 70,922 shares of the company's stock, valued at $32,890,077.50. The trade was a 13.81 % decrease in their position. The disclosure for this sale can be found here. 0.62% of the stock is owned by corporate insiders.

Synopsys Stock Up 1.1 %

NASDAQ SNPS traded up $5.13 during trading hours on Monday, hitting $477.41. The company's stock had a trading volume of 1,074,568 shares, compared to its average volume of 1,096,741. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $624.80. The firm has a market capitalization of $73.82 billion, a P/E ratio of 32.88, a PEG ratio of 3.23 and a beta of 1.23. The stock has a fifty day moving average of $434.75 and a 200 day moving average of $489.54.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the stock. Wells Fargo & Company lowered their target price on shares of Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a report on Thursday, February 27th. Morgan Stanley dropped their price objective on shares of Synopsys from $625.00 to $590.00 and set an "overweight" rating for the company in a report on Monday, February 24th. Mizuho cut their target price on shares of Synopsys from $650.00 to $600.00 and set an "outperform" rating for the company in a research note on Tuesday, April 15th. Bank of America decreased their price target on Synopsys from $630.00 to $560.00 and set a "buy" rating on the stock in a research report on Wednesday, April 16th. Finally, Rosenblatt Securities reiterated a "buy" rating and issued a $660.00 price objective on shares of Synopsys in a research report on Tuesday, February 25th. One analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $613.43.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.